Firm creates at-home Covid screening kits
Like many genetic testing companies, Rancho Dominguez-based DxTerity Diagnostics Inc. has pivoted to Covid-19 testing, but with a special focus on testing employees before they return to the workplace.
Research teams also expand cancer genetics research
UCLA announced a couple of health care-related developments last month that had little to do with the Covid-19 pandemic.
Hires of Voermann, Nagji continue rapid expansion
GoodRx Inc., a Santa Monica-based company that allows consumers to price shop among pharmacies for prescription drugs, has appointed industry veterans to two key executive posts to help guide the company through a period of rapid expansion.
Pacific Clinics, Kheir Center to expand remote services
Two local health care clinics each received two grants last month to expand their telehealth services.
Culver City-based neurotech company HI, known as Kernel, has raised $53 million in a Series C funding round.
Monrovia biopharmaceutical company Xencor Inc. has entered into a strategic collaboration with Bay Area biopharma company Atreca Inc. to develop cancer treatments.
L.A.’s bioscience sector generated $44 billion in economic activity and nearly 196,000 jobs last year.
Startup puts focus on cancer and Covid-19
Santa Monica health tech startup Quantgene Inc. is one of dozens of companies racing to revolutionize cancer detection screening by using only a drop of blood instead of the intrusive biopsies prevalent today.
Company offering home-based kits
Temple City-based genetic testing firm Fulgent Genetics Inc. is joining the rush of companies with home-based Covid-19 tests, announcing the launch of its service after receiving emergency authorization approval from the Food and Drug Administration.
Company is addressing issues with electronic medical records
DearHealth Inc., a Venice-based health-tech disease management firm, is using artificial intelligence algorithms to develop a disease management app that crafts structured care and treatment programs tailored to individual patients.
Incubator is now home to 20 companies
The BioLabs LA incubator's 20 member companies have raised a total of $31 million over the past year to fund research and development of their therapies, medical devices and services.
NantKwest, ImmunityBio in the hunt for virus vaccine
Developments have been coming at a rapid clip since late May for the effort by two of Patrick Soon-Shiong’s companies — El Segundo-based NantKwest Inc. and ImmunityBio Inc. — to come up with a vaccine for Covid-19.
Company’s Covid-19 tests attract colleges nationwide
MiraDx Inc., a West Los Angeles-based molecular genetics company, is now signing up public and private universities and colleges across the country for its Covid-19 testing service.
Company seeks approval to expand use of Yescarta
Santa Monica pharmaceutical concern Kite Pharma has passed a key clinical trial milestone as it seeks to expand the use of one of its breakthrough drugs to treat a form of non-Hodgkin’s lymphoma cancer.
Hospital company boosts network with addition of 10,000 doctors
Palms-based hospital and physician group operator Prospect Medical Holdings Inc. has acquired three medical groups with about 10,000 physicians, nearly doubling the doctor count in its physician association holdings to about 21,000.